Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Low Price/Cash Ratio Value Stocks -- Ignore unavailable to you. Want to Upgrade?

To: stock leader who wrote (1880)	1/26/2022 8:32:09 PM
From: S. maltophilia	Read Replies (1) \| Respond to of 1931

Here's another- ALLK. As of the last 10Q. With ~54MM shares Their big product did exactly what it was supposed to, physiologically. Trouble is, it didn't address the patients' symptoms. They're, of course, burning cash. Maybe at a slower rate while they try some other applications for it.

To: stock leader who wrote (1880)	4/19/2022 7:09:03 PM
From: stock leader	Read Replies (1) \| Respond to of 1931

ABIO best sub-cash stock since late january of the three. ABIO has now decided to pursue strategies to maximize shareholder value, however i dont see a list of the alternatives ? Reasonable to say ABIO could liquidate for upper 2s. PULM /CLBS are down since then , ABIO up about 25%. since January